ADDED
As of March 1 1, 2026, the registrant had outstanding 7,300,406 shares of common stock, $ 0.0001 par value per share.
Important factors that could cause such differences include, but are not limited to: our current and future capital requirements and our ability to satisfy our capital needs through financing transactions or otherwise; our ability to meet the requirements of our existing debt facility; our product launches and market penetration plans; the execution of agreements with various providers for our solution; our ability to maintain our relationships with key partners; our ability to maintain or protect the validity of our U.S.
and other patents and other intellectual property; our ability to retain key executive members; our ability to internally develop new inventions and intellectual property; general market, political and economic conditions in the countries in which we operate, including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East; our ability to effectuate a strategic transaction; interpretations of current laws and the passages of future laws; and acceptance of our business model by investors.
Dario is registered as a trademark in the United States, China, Canada, Hong Kong, Australia, Brazil, the EU, and is also registered as a WO (WIPO registration).
DarioHealth is registered as a trademark in the United States, Israel, China, Canada, Australia, India, Japan, the EU, and as a WO.
All information included herein relating to shares or price per share reflects the 20-for-1 reverse stock split effected by us on August 28, 2025.
Business Overview We are a vertically integrated health intelligence platform with a mission to power the behavior changes that drive better health.
Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, AI built on that proprietary data, and a behavior change and coaching layer validated through over 100 peer-reviewed clinical studies.
and select international markets by providing our chronic condition management and patient engagement solutions across many different health conditions.
In total, we had 1 67 employer customers in 2025, up from 53 in 2024.
REMOVED
As of March 3, 2025, the registrant had outstanding 41,567,016 shares of common stock, $0.0001 par value per share.
When used in this Annual Report, the terms Dario, DarioHealth, the Company, we, our, and us refer to DarioHealth Corp., a Delaware corporation and our subsidiary LabStyle Innovation Ltd., an Israeli company, PsyInnovations Inc., a Delaware company, Twill, Inc., a Delaware company, Twill ISR Ltd, an Israeli company, and DarioHealth India Services Pvt.
Dario is registered as a trademark in the United States, Israel, China, Canada, Hong Kong, South Africa, Japan, Costa Rica, and Panama.
DarioHealth is registered as a trademark in the United States and Israel.
Business Overview We are a leading global digital health company with a mission to power the behavior changes that drive better health.
by providing our chronic condition management and patient engagement solutions across many different health conditions.
How We Generate Revenue All of our customers have an interest in value-based health outcomes and care and have begun to work with us to align various types of outcomes with innovative revenue models.
We differentiate ourselves versus our competitors by being willing to enter into risk-based agreements with performance guarantees that align the financial incentives with the employer, health plan, employee, plan member, and we deliver the best health outcomes at the most affordable price, thereby delivering the highest ROI.
Across all market segments, we follow a digital health engagement platform subscription revenue model that is priced upon either a per user population basis ( PMPM ) or a per engaged user basis ( PEMPM ), and in some cases a customer may employee both pricing options together.
These revenue models can also include milestone-based payments, as well as performance guarantees.